Advertisement

Topics

Cardinal Health Unloads China Biz to Shanghai Pharma in $1.2B Deal

19:00 EST 14 Nov 2017 | BioSpace

The transaction is expected to close by the end of Cardinal Health's fiscal year, subject to closing conditions and regulatory clearances.

Original Article: Cardinal Health Unloads China Biz to Shanghai Pharma in $1.2B Deal

NEXT ARTICLE

More From BioPortfolio on "Cardinal Health Unloads China Biz to Shanghai Pharma in $1.2B Deal"

Advertisement
Quick Search
Advertisement
Advertisement